Oil Prices Edge Higher as U.S. Seizes Sanctioned Venezuelan Tanker 
Rio Tinto Signs Interim Agreement With Yinhawangka Aboriginal Group Over Pilbara Mining Operations 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs 
Global Markets Slide as Tech Stocks Sink, Yields Rise, and AI Concerns Deepen 
Wall Street Futures Slip as Oracle Earnings Miss Reignites AI Spending Concerns 
Gold Prices Dip as Markets Absorb Dovish Fed Outlook; Silver Eases After Record High 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Asian Stocks Slip as Oracle Earnings Miss Sparks AI Profitability Concerns 
Gold Prices Slip Slightly in Asia as Silver Nears Record Highs on Dovish Fed Outlook 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Tabletop particle accelerator could transform medicine and materials science 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
A South Korean research team has developed a strip-type urine test that successfully diagnoses prostate and pancreatic cancer on-site by amplifying the optical signal of the metabolome in urine.
The joint research team is from the Korea Institute of Materials Science, Pohang University of Science and Technology, and Kyung Hee University
The surface-enhanced Raman scattering sensor that they developed can amplify the optical signal of the metabolome in urine by more than 1 billion times by forming a coral reef-shaped plasmonic nanomaterial on top of porous paper material.
A light irradiation after a 10-microliter urine droplet amplified signal of cancer metabolome on the sensor’s surface without the need to go through a separate analysis process,.
The application of an artificial intelligence-based analytical method for the spectrum signal generated through the irradiation of light into the urine can identify people with prostate cancer and pancreatic cancer with an accuracy of up to 99 percent.
